Title: Stricken language would be deleted from and underlined language would be added to present law.
Official Title: Stricken language would be deleted from and underlined language would be added to present law.
Number of Sections: 1
Source: versions - Act 570
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
Act 570 of the Regular Session
1 State of Arkansas As Engrossed: H3/18/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1703
4
5 By: Representative L. Johnson
6 By: Senator Irvin
7
For An Act To Be Entitled
8
9 AN ACT TO PROVIDE A DRUG REIMBURSEMENT PROCESS FOR
10 CERTAIN HEALTHCARE PROVIDERS; AND FOR OTHER PURPOSES.
11
12
Subtitle
13
14 TO PROVIDE A DRUG REIMBURSEMENT PROCESS
15 FOR CERTAIN HEALTHCARE PROVIDERS.
16
17 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
18
19 SECTION 1. Arkansas Code Title 23, Chapter 99, is amended to add an
20 additional subchapter to read as follows:
21
22 Subchapter 19 — Drug Reimbursement Process
23
24 23-99-1901. Definitions.
25 (a) As used in this subchapter:
26 (1) "Contracting entity” means a healthcare insurer or a
27 subcontractor, affiliate, or other entity that contracts directly or
28 indirectly with a healthcare provider for the delivery of healthcare services
29 to patients;
30 (2)(A) "Drug" means a substance prescribed, administered, or
31 employed by a healthcare provider that is used to prevent, diagnose, treat,
32 or relieve symptoms of a disease, injury, or abnormal condition.
33 (B) "Drug" includes a prescription drug, medicine,
34 biological product, pharmaceutical, radiopharmaceutical, or other medical
35 supply;
36 (3)(A) "Health benefit plan" means a plan, policy, contract,
*ANS211*
03-18-2025 10:58:48 ANS211
As Engrossed: H3/18/25 HB1703
1 certificate, agreement, or other evidence of coverage for healthcare services
2 offered or issued by a healthcare insurer in this state.
3 (B) "Health benefit plan" includes indemnity and managed
4 care plans.
5 (C) "Health benefit plan" does not include:
6 (i) A plan that provides only dental benefits or eye
7 and vision care benefits;
8 (ii) A disability income plan;
9 (iii) A credit insurance plan;
10 (iv) Insurance coverage issued as a supplement to
11 liability insurance;
12 (v) A medical payment under an automobile or
13 homeowners insurance plan;
14 (vi) A health benefit plan provided under Arkansas
15 Constitution, Article 5, § 32, the Workers' Compensation Law, § 11-9-101 et
16 seq., or the Public Employee Workers' Compensation Act, § 21-5-601 et seq.;
17 (vii) A plan that provides only indemnity for
18 hospital confinement;
19 (viii) An accident-only plan;
20 (ix) A specified disease plan;
21 (x) A long-term-care-only plan; or
22 (xi) Nonfederal governmental plans as defined in 29
23 U.S.C. § 1002(32), as it existed on January 1, 2025;
24 (4)(A) "Healthcare insurer" means an entity that is subject to
25 state insurance regulation and provides health insurance in this state.
26 (B) "Healthcare insurer" includes:
27 (i) An insurance company;
28 (ii) A health maintenance organization; or
29 (iii) A hospital and medical service corporation.
30 (C) "Healthcare insurer" does not include an entity that
31 provides only dental benefits or eye and vision care benefits;
32 (5) "Healthcare provider" means a person or entity that is
33 licensed, certified, or otherwise authorized by the laws of this state to
34 provide healthcare services; and
35 (6)(A) "Healthcare services" means services or goods provided
36 for the purpose of or incidental to the purpose of preventing, diagnosing,
2 03-18-2025 10:58:48 ANS211
As Engrossed: H3/18/25 HB1703
1 treating, alleviating, relieving, curing, or healing human illness, disease,
2 condition, disability, or injury.
3 (B) "Healthcare services” includes services for the
4 diagnosis, prevention, treatment, or cure of a condition, illness, injury, or
5 disease.
6 (C) "Healthcare services" does not include a service
7 reimbursed through a pharmacy benefits manager licensed under the Arkansas
8 Pharmacy Benefits Manager Licensure Act, § 23-92-501 et seq.
9
10 23-99-1902. Drug reimbursement process.
11 (a)(1) A contracting entity shall provide a reasonable administrative
12 appeal procedure to allow a healthcare provider to challenge the
13 reimbursement for a specific drug as being below the healthcare provider’s
14 drug acquisition cost.
15 (2) The reasonable administrative appeal procedure under
16 subdivision (a)(1) of this section shall include:
17 (A) A dedicated telephone number, email address, and
18 website for the purpose of submitting an administrative appeal;
19 (B) The ability to submit an administrative appeal
20 directly to the healthcare insurer or health benefit plan; and
21 (C) The ability to file an administrative appeal no less
22 than sixty (60) business days following the adjudication of a claim.
23 (b) If a challenge is made under subsection (a) of this section,
24 within thirty (30) business days of receipt of the challenge, the contracting
25 entity shall:
26 (1) If the appeal is upheld:
27 (A) Make the change in the reimbursement rate to at least
28 one hundred ten percent (110%) of the healthcare provider’s drug acquisition
29 cost;
30 (B) Reprocess, or cause the healthcare insurer or health
31 benefit plan to reprocess, the claim in question at the reimbursement rate
32 established under subdivision (b)(1)(A) of this section; and
33 (C) Process, or cause the healthcare insurer or health
34 benefit plan to reprocess, any subsequent claim for the same drug, as
35 identified by the National Drug Code or Healthcare Common Procedure Coding
36 System, at the reimbursement rate established in subdivision (b)(1)(A) of
3 03-18-2025 10:58:48 ANS211
As Engrossed: H3/18/25 HB1703
1 this section; or
2 (2) If the appeal is denied, provide the challenging healthcare
3 provider with the specific information about the basis for the denial,
4 including without limitation any additional information necessary to
5 establish the drug acquisition cost.
6 (c) If an appeal is upheld under subdivision (b)(1) of this section, the
7 rate established by the appeal shall remain in place:
8 (1) For an appeal initiated before the last month of a
9 contracting entity’s fiscal quarter, until the end of the fiscal quarter that
10 the appeal was initiated; and
11 (2) For an appeal initiated within the last month of a
12 contracting entity’s fiscal quarter, until the end of the fiscal quarter
13 following the quarter that the appeal was initiated.
14 (d)(1) A healthcare provider may provide a quarterly notice to a
15 contracting entity of all drugs with an acquisition cost below the contracted
16 reimbursement rate.
17 (2) If a contracting entity receives notice under subdivision
18 (d)(1) of this section, the contracting entity may change the reimbursement
19 rates to at least one hundred ten percent (110%) of the healthcare provider’s
20 drug acquisition cost without an appeal under this section.
21
22 /s/L. Johnson
23
24
25 APPROVED: 4/14/25
26
27
28
29
30
31
32
33
34
35
36
4 03-18-2025 10:58:48 ANS211
[DELETED:  A   EBL1     A C   T F  B   S a  S   2  (   ( s i t   ( e o    ( b s   (]
[DELETED:  H2 0 c o    ( c    (     ( a     (     (     ( l     ( h     ( C s     ( h     (     (     (     ( U   ( s    (     (     (     (    ( p   ( l p   ( f]
[DELETED:  H3 0 t c    ( d d    ( r P   2  ( a r d   ( s    ( w    ( d    ( t  ( w e   (    ( o c    ( b e    ( b i S]
[DELETED:  H4 0 t   ( p i e ( r   ( c t   ( c f  ( c r   ( ( r d  /   A           ]


================================================================================

Raw Text:
Stricken language would be deleted from and underlined language would be added to present law.
Act 570 of the Regular Session
1 State of Arkansas As Engrossed: H3/18/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1703
4
5 By: Representative L. Johnson
6 By: Senator Irvin
7
For An Act To Be Entitled
8
9 AN ACT TO PROVIDE A DRUG REIMBURSEMENT PROCESS FOR
10 CERTAIN HEALTHCARE PROVIDERS; AND FOR OTHER PURPOSES.
11
12
Subtitle
13
14 TO PROVIDE A DRUG REIMBURSEMENT PROCESS
15 FOR CERTAIN HEALTHCARE PROVIDERS.
16
17 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
18
19 SECTION 1. Arkansas Code Title 23, Chapter 99, is amended to add an
20 additional subchapter to read as follows:
21
22 Subchapter 19 — Drug Reimbursement Process
23
24 23-99-1901. Definitions.
25 (a) As used in this subchapter:
26 (1) "Contracting entity” means a healthcare insurer or a
27 subcontractor, affiliate, or other entity that contracts directly or
28 indirectly with a healthcare provider for the delivery of healthcare services
29 to patients;
30 (2)(A) "Drug" means a substance prescribed, administered, or
31 employed by a healthcare provider that is used to prevent, diagnose, treat,
32 or relieve symptoms of a disease, injury, or abnormal condition.
33 (B) "Drug" includes a prescription drug, medicine,
34 biological product, pharmaceutical, radiopharmaceutical, or other medical
35 supply;
36 (3)(A) "Health benefit plan" means a plan, policy, contract,
*ANS211*
03-18-2025 10:58:48 ANS211

As Engrossed: H3/18/25 HB1703
1 certificate, agreement, or other evidence of coverage for healthcare services
2 offered or issued by a healthcare insurer in this state.
3 (B) "Health benefit plan" includes indemnity and managed
4 care plans.
5 (C) "Health benefit plan" does not include:
6 (i) A plan that provides only dental benefits or eye
7 and vision care benefits;
8 (ii) A disability income plan;
9 (iii) A credit insurance plan;
10 (iv) Insurance coverage issued as a supplement to
11 liability insurance;
12 (v) A medical payment under an automobile or
13 homeowners insurance plan;
14 (vi) A health benefit plan provided under Arkansas
15 Constitution, Article 5, § 32, the Workers' Compensation Law, § 11-9-101 et
16 seq., or the Public Employee Workers' Compensation Act, § 21-5-601 et seq.;
17 (vii) A plan that provides only indemnity for
18 hospital confinement;
19 (viii) An accident-only plan;
20 (ix) A specified disease plan;
21 (x) A long-term-care-only plan; or
22 (xi) Nonfederal governmental plans as defined in 29
23 U.S.C. § 1002(32), as it existed on January 1, 2025;
24 (4)(A) "Healthcare insurer" means an entity that is subject to
25 state insurance regulation and provides health insurance in this state.
26 (B) "Healthcare insurer" includes:
27 (i) An insurance company;
28 (ii) A health maintenance organization; or
29 (iii) A hospital and medical service corporation.
30 (C) "Healthcare insurer" does not include an entity that
31 provides only dental benefits or eye and vision care benefits;
32 (5) "Healthcare provider" means a person or entity that is
33 licensed, certified, or otherwise authorized by the laws of this state to
34 provide healthcare services; and
35 (6)(A) "Healthcare services" means services or goods provided
36 for the purpose of or incidental to the purpose of preventing, diagnosing,
2 03-18-2025 10:58:48 ANS211

As Engrossed: H3/18/25 HB1703
1 treating, alleviating, relieving, curing, or healing human illness, disease,
2 condition, disability, or injury.
3 (B) "Healthcare services” includes services for the
4 diagnosis, prevention, treatment, or cure of a condition, illness, injury, or
5 disease.
6 (C) "Healthcare services" does not include a service
7 reimbursed through a pharmacy benefits manager licensed under the Arkansas
8 Pharmacy Benefits Manager Licensure Act, § 23-92-501 et seq.
9
10 23-99-1902. Drug reimbursement process.
11 (a)(1) A contracting entity shall provide a reasonable administrative
12 appeal procedure to allow a healthcare provider to challenge the
13 reimbursement for a specific drug as being below the healthcare provider’s
14 drug acquisition cost.
15 (2) The reasonable administrative appeal procedure under
16 subdivision (a)(1) of this section shall include:
17 (A) A dedicated telephone number, email address, and
18 website for the purpose of submitting an administrative appeal;
19 (B) The ability to submit an administrative appeal
20 directly to the healthcare insurer or health benefit plan; and
21 (C) The ability to file an administrative appeal no less
22 than sixty (60) business days following the adjudication of a claim.
23 (b) If a challenge is made under subsection (a) of this section,
24 within thirty (30) business days of receipt of the challenge, the contracting
25 entity shall:
26 (1) If the appeal is upheld:
27 (A) Make the change in the reimbursement rate to at least
28 one hundred ten percent (110%) of the healthcare provider’s drug acquisition
29 cost;
30 (B) Reprocess, or cause the healthcare insurer or health
31 benefit plan to reprocess, the claim in question at the reimbursement rate
32 established under subdivision (b)(1)(A) of this section; and
33 (C) Process, or cause the healthcare insurer or health
34 benefit plan to reprocess, any subsequent claim for the same drug, as
35 identified by the National Drug Code or Healthcare Common Procedure Coding
36 System, at the reimbursement rate established in subdivision (b)(1)(A) of
3 03-18-2025 10:58:48 ANS211

As Engrossed: H3/18/25 HB1703
1 this section; or
2 (2) If the appeal is denied, provide the challenging healthcare
3 provider with the specific information about the basis for the denial,
4 including without limitation any additional information necessary to
5 establish the drug acquisition cost.
6 (c) If an appeal is upheld under subdivision (b)(1) of this section, the
7 rate established by the appeal shall remain in place:
8 (1) For an appeal initiated before the last month of a
9 contracting entity’s fiscal quarter, until the end of the fiscal quarter that
10 the appeal was initiated; and
11 (2) For an appeal initiated within the last month of a
12 contracting entity’s fiscal quarter, until the end of the fiscal quarter
13 following the quarter that the appeal was initiated.
14 (d)(1) A healthcare provider may provide a quarterly notice to a
15 contracting entity of all drugs with an acquisition cost below the contracted
16 reimbursement rate.
17 (2) If a contracting entity receives notice under subdivision
18 (d)(1) of this section, the contracting entity may change the reimbursement
19 rates to at least one hundred ten percent (110%) of the healthcare provider’s
20 drug acquisition cost without an appeal under this section.
21
22 /s/L. Johnson
23
24
25 APPROVED: 4/14/25
26
27
28
29
30
31
32
33
34
35
36
4 03-18-2025 10:58:48 ANS211

[DELETED:  A   EBL1     A C   T F  B   S a  S   2  (   ( s i t   ( e o    ( b s   (]
[DELETED:  H2 0 c o    ( c    (     ( a     (     (     ( l     ( h     ( C s     ( h     (     (     (     ( U   ( s    (     (     (     (    ( p   ( l p   ( f]
[DELETED:  H3 0 t c    ( d d    ( r P   2  ( a r d   ( s    ( w    ( d    ( t  ( w e   (    ( o c    ( b e    ( b i S]
[DELETED:  H4 0 t   ( p i e ( r   ( c t   ( c f  ( c r   ( ( r d  /   A           ]